Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
Cheung MW, Dayam RM, Shapiro JR, Law JC, Chao GYC, Pereira D, Goetgebuer RL, Croitoru D, Stempak JM, Acheampong L, Rizwan S, Lee JD, Jacob L, Ganatra D, Law R, Rodriguez-Castellanos VE, Kern-Smith M, Delgado-Brand M, Mailhot G, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Watts TH, Gingras AC. Cheung MW, et al. Among authors: dayam rm. J Immunol. 2023 Aug 1;211(3):351-364. doi: 10.4049/jimmunol.2300190. J Immunol. 2023. PMID: 37326480 Free PMC article.
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination.
Walmsley S, Nabipoor M, Lovblom LE, Ravindran R, Colwill K, McGeer A, Dayam RM, Manase D, Gingras AC, On Behalf Of The STOPCoV Team. Walmsley S, et al. Among authors: dayam rm. Vaccines (Basel). 2023 Dec 28;12(1):36. doi: 10.3390/vaccines12010036. Vaccines (Basel). 2023. PMID: 38250849 Free PMC article.
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
Bowdish DME, Chandran V, Hitchon CA, Kaplan GG, Avina-Zubieta JA, Fortin PR, Larché MJ, Boire G, Gingras AC, Dayam RM, Colmegna I, Lukusa L, Lee JLF, Richards DP, Pereira D, Watts TH, Silverberg MS, Bernstein CN, Lacaille D, Benoit J, Kim J, Lalonde N, Gunderson J, Allard-Chamard H, Roux S, Quan J, Hracs L, Turnbull E, Valerio V, Bernatsky S; SUCCEED Investigative Team. Bowdish DME, et al. Among authors: dayam rm. J Rheumatol. 2024 Jul 1;51(7):721-727. doi: 10.3899/jrheum.2023-1214. J Rheumatol. 2024. PMID: 38621797 Free article.
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination.
Walmsley S, Nabipoor M, Qi F, Lovblom LE, Ravindran R, Colwill K, Dayam RM, Tursun TR, Silva A, Gingras AC, On Behalf Of The STOPCoV Team. Walmsley S, et al. Among authors: dayam rm. Vaccines (Basel). 2024 May 22;12(6):564. doi: 10.3390/vaccines12060564. Vaccines (Basel). 2024. PMID: 38932293 Free PMC article.
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort Study.
Habib R, Dayam RM, Hitchon C, Chandran V, Fortin PR, Boire G, Bowdish DME, Gingras AC, Flamand L, Larché MJ, Colmegna I, Lukusa L, Lee JLF, Pereira D, Bernstein CN, Lalonde N, Turnbull E, Bernatsky S; SUCCEED investigative team. Habib R, et al. Among authors: dayam rm. ACR Open Rheumatol. 2024 Sep;6(9):581-586. doi: 10.1002/acr2.11697. Epub 2024 Jul 1. ACR Open Rheumatol. 2024. PMID: 38952080 Free PMC article.
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study.
Hitchon CA, Bowdish DME, Boire G, Fortin PR, Flamand L, Chandran V, Dayam RM, Gingras AC, Card CM, Colmegna I, Larché MJ, Kaplan GG, Lukusa L, Lee JLF, Bernatsky S, On Behalf Of The Succeed Investigative Team. Hitchon CA, et al. Among authors: dayam rm. Vaccines (Basel). 2024 Sep 17;12(9):1061. doi: 10.3390/vaccines12091061. Vaccines (Basel). 2024. PMID: 39340091 Free PMC article.
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series.
Walmsley SL, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A, Graham C, Silva A, Manase D, Maksymowsky P, Parente L, Dayam RM, Simpson J, Pasculescu A, Gingras AC. Walmsley SL, et al. Among authors: dayam rm. iScience. 2023 Apr 21;26(4):106506. doi: 10.1016/j.isci.2023.106506. Epub 2023 Mar 28. iScience. 2023. PMID: 37073374 Free PMC article.
21 results